ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
5 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
31 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
31
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
22 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
22
|
|
ASX - By Stock
|
PAR |
Re:
Symptomatic relief is one thing...
|
|
Torpy
|
7 |
4.2K |
7 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
7
|
4.2K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Increases Presence at OARSI World Congress 2023
|
|
Torpy
|
117 |
45K |
23 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
117
|
45K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
19 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
670
|
256K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm Needs you!
|
|
Torpy
|
79 |
32K |
6 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
79
|
32K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Paul Rennie interviewed on Marcus Today Podcast.
|
|
Torpy
|
42 |
12K |
7 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
42
|
12K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
This can't be true...
|
|
Torpy
|
10 |
4.8K |
7 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
10
|
4.8K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR Broker Data
|
|
Torpy
|
336 |
146K |
3 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
336
|
146K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Mozz Research 2022
|
|
Torpy
|
24 |
9.6K |
22 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
24
|
9.6K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Torpy
|
141 |
57K |
20 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
141
|
57K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
16 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
670
|
256K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Torpy
|
141 |
57K |
7 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
141
|
57K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the Leading Lady
|
|
Torpy
|
22 |
7.6K |
14 |
27/11/22 |
27/11/22 |
ASX - By Stock
|
22
|
7.6K
|
14
|
|
ASX - By Stock
|
XRO |
Re:
Ann: H1 FY23 Investor Presentation
|
|
Torpy
|
95 |
77K |
5 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
95
|
77K
|
5
|
|
ASX - By Stock
|
XRO |
Re:
Ann: H1 FY23 Investor Presentation
|
|
Torpy
|
95 |
77K |
1 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
95
|
77K
|
1
|
|
ASX - By Stock
|
XRO |
Re:
Ann: H1 FY23 Investor Presentation
|
|
Torpy
|
95 |
77K |
10 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
95
|
77K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
16 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Competition???
|
|
Torpy
|
61 |
25K |
23 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
61
|
25K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
21 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
21
|
|
ASX - By Stock
|
PAR |
Re:
Potential Financial Implications of Yesterday's Results
|
|
Torpy
|
97 |
44K |
15 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
97
|
44K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial
|
|
Torpy
|
115 |
64K |
35 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
115
|
64K
|
35
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful MPSVI Safety Review and PARA OA 008 Update
|
|
Torpy
|
104 |
40K |
7 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
104
|
40K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
The Countdown is on...
|
|
Torpy
|
5 |
3.7K |
12 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
5
|
3.7K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
16 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful Completion of Entitlement Offer
|
|
Torpy
|
109 |
39K |
5 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
109
|
39K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
5 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful Completion of Entitlement Offer
|
|
Torpy
|
109 |
39K |
11 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
109
|
39K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
10 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
670
|
256K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
9 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
1 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
670
|
256K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
2b or NOT to be
|
|
Torpy
|
84 |
30K |
2 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
84
|
30K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
5 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
1 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2022 Annual Report and Appendix 4E
|
|
Torpy
|
26 |
10K |
6 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
26
|
10K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
9 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
17 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Becoming a substantial holder
|
|
Torpy
|
31 |
11K |
24 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
31
|
11K
|
24
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Doses First US Subjects under Phase 3 trial
|
|
Torpy
|
58 |
24K |
6 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
58
|
24K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Launches $66M Capital Raising
|
|
Torpy
|
132 |
56K |
5 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
132
|
56K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR Broker Data
|
|
Torpy
|
336 |
146K |
7 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
336
|
146K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Torpy
|
276 |
107K |
3 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
276
|
107K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
The novel drug - A DMOAD approach
|
|
Torpy
|
36 |
14K |
8 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
36
|
14K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
WTF- what's with the share price movement
|
|
Torpy
|
129 |
59K |
5 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
129
|
59K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm on the television .
|
|
Torpy
|
63 |
26K |
17 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
63
|
26K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
12 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
5 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
The Humira comparative, and how about a bonus?
|
|
Torpy
|
23 |
10K |
14 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
23
|
10K
|
14
|
|
ASX - By Stock
|
PAR |
Re:
A most comprehensive exploratory study...
|
|
Torpy
|
16 |
6.9K |
6 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
16
|
6.9K
|
6
|
|